Up next

Autoplay

EASL Studio - S3E16 - Liver cancer in 2022: Wrap-up & outlook

1 Views • 07/13/23
Share
Embed
administrator
administrator
Subscribers
0

Results from current clinical trials are rapidly evolving, with mixed results. In this EASL Studio the faculty discuss:

why certain trials have failed whereas others have succeeded,
what we have learned about the connection between overall survival and progression-free survival as endpoints, and
how the systemic therapy of HCC has evolved.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay